Your browser doesn't support javascript.
loading
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID­19 and associated cancers and diseases.
Zalpoor, Hamidreza; Akbari, Abdullatif; Nabi-Afjadi, Mohsen.
Affiliation
  • Zalpoor H; American Association of Kidney Patients, Tampa, FL, USA.
  • Akbari A; Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Nabi-Afjadi M; Network of Immunity in Infection, Malignancy & Autoimmunity (NIIMA), Universal Scientific Education & Research Network (USERN), Tehran, Iran.
Hum Cell ; 35(3): 952-954, 2022 05.
Article in En | MEDLINE | ID: mdl-35377105
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, EphA1 / COVID-19 / Neoplasms Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Hum Cell Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptor, EphA1 / COVID-19 / Neoplasms Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Hum Cell Year: 2022 Document type: Article Affiliation country: Country of publication: